Sofinnova Partners | Sofinnova MD Start IV
◆ Fund Size
$650M
◆ Location
France
◆ Portfolio
500 companies
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
European life sciences venture capital with a medtech company-creation strategy focused on launching and supporting early-stage medtech companies from inception through key clinical and operational milestones; the newly announced Sofinnova MD Start IV is expected to expand this strategy across Europe and the US and to launch six to eight new medtech companies over the next five years.
◆ About Sofinnova Partners
A €82 million medtech-focused venture fund dedicated to creating and supporting new medtech companies from inception through clinical and operational milestones across Europe and the US. The fund plans to launch six to eight new medtech companies over the next five years.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Anta Gkelou | Partner | Senior | |
| Antoine Papiernik | Chairman & Managing Partner | Senior | in𝕏 |
| Graziano Seghezzi | Managing Partner | Senior | in |
| Henrijette Richter | Managing Partner | Senior | |
| Karl Naegler | Partner | Senior | |
| Maina Bhaman | Partner | Senior | |
| Anne Osdoit | Deal lead | — | |
| Cedric Moreau | Partner | Partner | |
| Claire Catherinet | Senior Associate | Senior Associate | |
| Edward Kliphuis | Deal lead | — | |
| Elliott Puttock | Analyst | Analyst | |
| Guillaume Baxter | Deal lead | — | |
| Jacques Theurillat | Partner | Partner | |
| Joe Anderson | Partner | Partner | |
| Joško Bobanović | Deal lead | — | |
| Kinam Hong | Partner | Partner | |
| Lucia Faccio | Deal lead | — | |
| Mano Iyer | Deal lead | — | |
| Michael Krel | Deal lead | — | |
| Monique Saulnier | Deal lead | — | |
| Paola Pozzi | Deal lead | — | |
| Simon Turner | Deal lead | — |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Sofinnova MD Start IV invest in?
Sofinnova MD Start IV invests in Medtech at the pre-seed, seed, series-a and series-b stages.
Which geographies does Sofinnova MD Start IV focus on?
Sofinnova MD Start IV focuses on Europe and United States, and is headquartered in France.